GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia

Minerva Gastroenterologica e Dietologica

Volumn 60, Issue 1, 2014, Pages 79-83

  Masci, E ^a   Pellicano, R ^b   Mangiavillano, B ^a   Luigiano, C ^c   Stelitano, L ^d   Morace, C ^d   Viale, E ^e   Freschi, M ^e   Locatelli, M ^e   Ieri, R ^e   Cavallaro, A ^e   Testoni, S ^e   Testoni, P A ^e  

^a SAN PAOLO HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c ARNAS Garibaldi   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Atrophic Helicobacter pylori Endoscopy; Digestive system; Gastritis

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; ATROPHY; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; GASTROINTESTINAL BIOPSY; GASTROPANEL TEST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MALE; NON INVASIVE MEASUREMENT; PREDICTION; SENSITIVITY ANALYSIS;

ADULT; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; BIOPSY; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84899676988     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Luigiano C, Ferrara F, Fagoonee S, Fabbri C, Cennamo V, Virgilio C et al. Is Helicobacter pylori the infectious target to prevent gastric cancer? An interdisciplinary point of view. Infect Disord Drug Targets 2012;12:340-5.
2. Morace C, Luigiano C, Fagoonee S, Consolo P, Saracco G, Pellicano R. Molecular findings on Helicobacter pylori: update for clinicians. Minerva Gastroenterol Dietol 2011;57:387-94.
3. Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 1998;93:569-73. (Pubitemid 29081004)
4. Dixon MF, Genta R, Yardley J, Correa P; the participants in the International Workshop on the histopathology of gastritis, Houston 1994. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
5. Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010;48:1327-32.
6. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2-10. (Pubitemid 46033039)
7. Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S et al. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer 2005;115:463-9. (Pubitemid 40663752)
8. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-42. (Pubitemid 27342688)
9. Väänänen H, Vauhkonen M, Helske T, Kääriä inen I, Rasmussen M, Tunturi-Hihnala H et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91. (Pubitemid 36904458)
10. Rembiasz K, Konturek PC, Karcz D, Konturek SJ, Ochmanski W, Bielanski W et al. Biomarkers in various types of atrophic gastritis and their diagnostic usefulness. Dig Dis Sci 2005;50:474-82. (Pubitemid 40543735)
11. Pasechnikov VD, Chukov SZ, Kotelevets SM, Mostovov AN, Mernova VP, Polyakova MB. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand J Gastroenterol 2005;40:297-301. (Pubitemid 40476460)
12. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009;15:853-9.
13. Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006;4:306-14. (Pubitemid 43343886)
14. Valle Muñoz J, Artaza Varasa T, López Pardo R, Rodríguez Merlo R, Pérez Grueso MJ, Martín Escobedo R et al. Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies. Gastroenterol Hepatol 2007;30:567-71. (Pubitemid 350256384)
15. Mohamadkhani A, Moghaddam SD, Salmanroghani H, Allafsghari A, Yazdanbod A, Mirzaei M et al. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence? Arch Iran Med 2013;16:208-12.
16. Marotta F, Hayakawa K, Mikami Y, Morello P, Sugai M, Morita T. Relationship between gastrin cell number, serum, antral mucosa and luminal gastrin concentration and gastric acidity in antral atrophic gastritis. Gut 1990;31:279-81. (Pubitemid 20093662)
17. Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004;99:1910-5. (Pubitemid 39421232)